Second Look Lab — Research Brief: Two approved-drug routes to reducing glial encapsulation of implanted neural electrodes
Hypothesis-generating brief from Second Look Lab, an independent drug-repurposing project. Not medical advice; no human dosing is proposed and no claim of efficacy in humans is made. Chronic intracortical electrodes fail largely because the brain encapsulates them, and almost all effort on this problem is directed at materials, geometry and coatings. We instead searched for a systemically administered, already-approved drug with a measured effect on that encapsulation and no clinical follow-up. Route 1: NHE-1 inhibition. PMID 33621208 (J Neural Eng, 2021) reported that systemic HOE-642 (cariporide) reduced microglial encapsulation of implanted intracortical microelectrodes from 50.7 +/- 6.0% to 8.9 +/- 6.1% at 5 h, and the activation radius from 222.2 to 177.9 um at 72 h, with no effect on migration rate. There has been no follow-up in five years. Cariporide itself is not approved and its cardiac-surgery programme ended with an excess of cerebrovascular events. Rimeporide, a different NHE-1 inhibitor, has completed a Phase 1 study in humans (NCT02710591) and has been tested side by side with HOE-642 in mouse brain after ischaemic stroke (PMID 37686096), with reduced neuroinflammation and improved recovery. No published work joins these three facts. Route 2, weaker and stated as such: valproic acid inhibits glial scar formation after ischaemic stroke (PMID 35316816), and as of 21 November 2026 ClinicalTrials.gov lists no registered trial of valproic acid in glial scar or in neural implants. Eight weaknesses are stated by the authors in the brief itself, including that the headline measurement is acute, that reduced encapsulation is not the same as preserved recording quality, and that cross-literature convergence is weak evidence. Method, counts of discarded candidates and the reasons for each discard are given in the brief. Register of checked and rejected ideas: https://secondlooklab.pages.dev
Authors
- Second Look Lab
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24422856
- Primary Topic
- Neuroscience and Neural Engineering
- Type
- preprint